Carol A.  Surface net worth and biography

Carol Surface Biography and Net Worth

SVP of Medtronic
Carol Surface joined Medtronic in September 2013 and currently serves as Executive Vice President and Chief Human Resources Officer. She leads Medtronic’s human resources strategy for 90,000+ employees worldwide. She also provides leadership for Philanthropy and Medtronic Labs, and serves as the Board Chair of the Medtronic Foundation. Key focus areas include organizational transformation, enterprise talent management and succession planning, leadership development, inclusion and diversity, executive compensation, and community and health initiatives.

Prior to joining Medtronic, Carol served as Executive Vice President and Chief Human Resources Officer at Best Buy Co., Inc., a leading provider of technology products, services, and solutions. Carol also held a series of human resources leadership roles at PepsiCo, including serving as Chief Personnel Officer for PepsiCo International. She has lived and worked in Asia, the Middle East, and the United States.

Carol serves as Vice Chair of the HR Policy Association, Co-Chair of Gartner’s CHRO Leadership Board, and is a member of the Advisory Board of the University of South Carolina Center for Executive Succession. She also serves on the Greater MSP Board of Directors in the Minneapolis community. Additionally, she is a member of The Society for Industrial and Organizational Psychology. In 2020, Carol was elected as Fellow of the National Academy of Human Resources (NAHR), the highest honor granted in the human resource profession. She earned a Ph.D. in industrial/organizational psychology from Central Michigan University.

How do I contact Carol A. Surface?

The corporate mailing address for Dr. Surface and other Medtronic executives is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. Medtronic can also be reached via phone at (531) 438-1700 and via email at [email protected]. Learn More on Carol A. Surface's contact information.

Has Carol A. Surface been buying or selling shares of Medtronic?

Carol A. Surface has not been actively trading shares of Medtronic in the last ninety days. Most recently, Carol A. Surface sold 6,000 shares of the business's stock in a transaction on Friday, March 11th. The shares were sold at an average price of $105.30, for a transaction totalling $631,800.00. Learn More on Carol A. Surface's trading history.

Who are Medtronic's active insiders?

Medtronic's insider roster includes Richard Anderson (Director), Michael Coyle (EVP), Gary Ellis (EVP), Hooman Hakami (EVP), Bryan Hanson (EVP), Omar Ishrak (Chairman), Richard Kuntz (SVP), Bradley Lerman (SVP), John Liddicoat (EVP), Michael Marinaro (EVP), Geoffrey Martha (CEO), Karen Parkhill (CFO), Sean Salmon (EVP), Gregory Smith (EVP), Carol Surface (SVP), Rob Ten Hoedt (EVP), Brett Wall (EVP), Brett Wall (EVP), and Robert White (EVP). Learn More on Medtronic's active insiders.

Are insiders buying or selling shares of Medtronic?

During the last year, insiders at the medical technology company sold shares 4 times. They sold a total of 55,659 shares worth more than $4,695,766.41. The most recent insider tranaction occured on June, 7th when CEO Geoffrey Martha sold 19,113 shares worth more than $1,601,096.01. Insiders at Medtronic own 0.2% of the company. Learn More about insider trades at Medtronic.

Information on this page was last updated on 6/7/2024.

Carol A. Surface Insider Trading History at Medtronic

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/11/2022Sell6,000$105.30$631,800.00View SEC Filing Icon  
12/28/2020Sell15,000$114.90$1,723,500.00View SEC Filing Icon  
5/29/2020Sell2,000$97.72$195,440.00View SEC Filing Icon  
6/17/2019Sell9,000$97.66$878,940.00View SEC Filing Icon  
3/5/2018Sell24,479$78.18$1,913,768.22View SEC Filing Icon  
7/6/2016Sell9,787$87.08$852,251.96View SEC Filing Icon  
7/14/2015Sell13,722$75.83$1,040,539.26View SEC Filing Icon  
See Full Table

Carol A. Surface Buying and Selling Activity at Medtronic

This chart shows Carol A Surface's buying and selling at Medtronic by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Medtronic Company Overview

Medtronic logo
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Read More

Today's Range

Now: $87.72
Low: $87.57
High: $88.69

50 Day Range

MA: $89.68
Low: $87.04
High: $92.27

2 Week Range

Now: $87.72
Low: $69.32
High: $92.68

Volume

8,137,674 shs

Average Volume

4,969,610 shs

Market Capitalization

$112.50 billion

P/E Ratio

29.64

Dividend Yield

3.11%

Beta

0.84